Skip to content

ITRM

Iterum Therapeutics Plc

NASDAQ · Healthcare · Biotechnology · IE

$0.03
−10.98%
Ask drillr

Latest reported

Last report date
Nov 14, 2025
EPS actual
-$0.20
EPS estimate
-$0.13
Revenue actual
$390.0K
Revenue estimate
—

Track record

Trailing twelve quarters

EPS beats (12Q)
7
EPS misses (12Q)
5
EPS in line (12Q)
0
Avg surprise (4Q)
+2.0%
Revenue beats (12Q)
—
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Nov 14, 2025-$0.13-$0.20Miss -53.85%$390.0K
Feb 7, 2025-$0.24-$0.12Beat 50.00%—
Nov 14, 2024-$0.23-$0.30Miss -30.43%—
Aug 14, 2024-$0.52-$0.30Beat 42.31%—
Nov 14, 2023-$0.91-$0.30Beat 67.03%—
Aug 11, 2023-$0.80-$0.95Miss -18.75%—
May 12, 2023-$0.80-$0.78Beat 2.50%—
Mar 16, 2023-$1.22-$0.41Beat 66.39%—
Nov 10, 2022-$1.00-$2.38Miss -138.00%—
Aug 12, 2022-$1.05-$0.60Beat 42.86%—
May 13, 2022-$0.75-$0.30Beat 60.00%—
Nov 12, 2021$1.80$0.30Miss -83.33%—

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Apr 3, 2026